Teva announced the launch of Linezolid Injection, the generic version of Pfizer’s Zyvox Injection.

Zyvox injection is an oxazolidinedione antibiotic indicated for the treatment of infections caused by susceptible Gram (+) bacteria: nosocomial pneumonia, community-acquired pneumonia; complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis; uncomplicated skin and skin structure infections; and vancomycin-resistant Enterococcus faecium infections.

RELATED: Antibiotic Formulations

Linezolid Injection is available as a 600mg/300mL strength as 10-count single-use flexible plastic infusion bags.

For more information call (888) 838-2872 or visit